Canonsburg, Penn.-based Viatris yesterday became the 37th drugmaker to restrict the shipment of 340B-priced drugs in the contract pharmacy setting. [...] …
Articles by : William Newton, Associate Editor/Senior Writer
More Drugmakers Exempt States from Contract Pharmacy Restrictions as Four New State Laws Take Effect
Four major drug manufacturers announced they will fully or partially exempt covered entities in certain states from their 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Five new manufacturer restrictions on wholly-owned pharmacies taking effect in July will be “disastrous” for certain health center pharmacy arrangements, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two community health centers urged a federal appeals court to reverse an earlier dismissal of their lawsuit alleging four major [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Inflation Reduction Act (IRA) may reduce 340B margins for certain high-cost drugs and drive more transparency into the program, an influential pharmaceutical supply chain analyst who has been a frequent 340B critic told an audience of stakeholders late last
…
A powerful brand-name drug industry trade organization has asked a federal district judge to block Maryland from enforcing the state’s [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Fourteen years after the Congressional deadline, the long-anticipated revision to the 340B Administrative Dispute Resolution (ADR) process officially took effect [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A U.S. senator introduced a bill to extend 340B eligibility to certain outpatient rural hospitals with emergency services, mirroring a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key argument in AstraZeneca’s lawsuit challenging Arkansas’ 340B contract pharmacy access law has already been rejected by a higher [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug manufacturer Novartis uses contradictory, “whiplash-inducing” arguments in its lawsuit challenging Mississippi’s 340B contract pharmacy law, hospital groups told a [...] …
